Definitive diagnosis and definitive treatment in chronic venous disease: A concept whose time has come  by Kistner, Robert L.
ORIGINAl, ARTICLES 
From the American Venous Forum 
Definitive diagnosis and definitive treatment 
in chronic venous disease: A concept whose 
time has come 
Robert  L. Kistner, MD, Honolulu, Hawaii 
It has been a great honor for me to serve as 
President of  the American Venous Forum (AVF) 
during this past year, and I wish to thank the members 
of the society for giving me this wonderful experience. 
It is exciting to be associated with the AVF in its 
formative years, when opportunity abounds to con- 
tribute to the directions that the society will take as it 
pursues its purpose of  improving the care of the 
venous patient through research, education, and 
cfinical investigation of venous diseases. 
The stimulating opportunity to present a presi- 
dential address leads to global thoughts about the 
society and the specialty it represents. As one looks at 
the field ofvenous disease, there is a sense of an orphan 
specialty in search of a home. Venous disease involves 
many facets of medicine, but there is no single 
specialty that has adopted overall responsibility for it. 
Certainly it is a big enough field to warrant attention, 
because it affects as much as 50% of the adult 
population in one form or another. 1 Clearly it is a 
serious enough problem, with its acute manifestation 
of deep venous thrombosis (DVT) and pulmonary 
embolism representing a major cause of death, 2and its 
chronic form a leading cause of work disability. 
But the fact is that no specialty has taken full 
responsibility to study and "conquer" the problems 
of venous disease in the way that other major disease 
entities have been assumed by specialty areas, and 
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there have not been any great teaching institutions 
that have earned adominant reputation for managing 
venous disease in America. This leaves ahuge void that 
yearns to be filled. In my mind, the AVF is well 
constituted to become a major factor in tilling this 
void. 
The AVF has a high representation f  academia in 
its ranks, which gives rise to a strong accent on clinical 
and basic research in its proceedings. Because the 
impact hat an organization can produce is shaped by 
the individuals who make up the organization, I 
believe that the great contribution to be made by the 
AVF in the future will result from its ability to define 
basic principles of diagnosis and treatment because of 
its research and teaching capability. A recent example 
of this ability was Dr. Hobson's presidential ddress 3 
to this society 1 year ago, which was devoted to the 
future of research in venous disease. 
As we move forward, it is clear that there is a need 
to organize the findings we accept as established 
"facts" in an orderly manner and to adopt a common 
language with definitions of terms to facilitate mean- 
ingful communication. This effort requires that we 
reexamine those beliefs that were so deeply ingrained 
in us by our teachers that were based on clinical 
impression but were not tested in the objective realm 
by reproducible methods. Over the years, pure clinical 
diagnosis in venous disease has been found to be 
inaccurate. This is true of many facets of venous 
disease, such as the clinical diagnosis of DVT, which 
has been proven unreliable; the clinical diagnosis of 
pulmonary embolism, which we recognize to be 
unreliable; and the clinical diagnosis of the postphle- 
bitic leg, which is also unreliable. 
If  it can be accepted that the veins function 
optimally when they are both patent and competent, 
then any other condition is a compromise with normal 
function and needs to be controlled by the compen- 
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sating capacity of the veins. It follows that the ideal of 
treatment is to restore both patency and competence 
to the diseased veins. When that restoration is not 
possible, partial correction will often result in a 
compensated state in which the venous drainage is 
restored sufficiently to allow the individual a normal 
way of life. The challenge is to identify the precise 
abnormalities that are present in the veins of patients 
who have chronic venous disease and to develop ways 
to either correct the abnormalities themselves or 
achieve acompensated state by ligation, stripping, or 
bypass that will improve patency and competence 
even if it cannot be totally corrected. 
Until the advent of the color-flow Doppler scan, 
and the even more explicit duplex scan, diagnosis in 
venous disease was dominated by superficial inspec- 
tion and professorial opinion that was based on 
experience without objective testing. The fallacy of 
this approach was forcefully made in acute venous 
disease by Dr. Jack Craniey and associates, 4 who 
pointed out that the clinical diagnosis of DVT is 
wrong half of the rime and that the errors occur both 
in false-positive and false-negative diagnoses. This 
realization gave purpose to the requirement for ob- 
jective diagnoses to justify treatment in DVT. My 
thesis is that these same principles need to be applied 
to chronic venous disease, in which clinical diagnoses 
can be equally deceiving. 
PRESENT STATUS IN CHRONIC 
VENOUS DISEASE 
In today's practice, the diagnosis of the patient 
who has chronic venous disease (CVD) is essentially 
random from doctor to doctor and from institution to 
institution. The completeness of the workup and the 
choice of test used to establish a diagnosis in CVD 
vary widely. The techniques of performing the venous 
tests and the quality control of the testing vary 
tremendously from laboratory to laboratory. Impre- 
cise terms uch as "chronic venous insufficiency" and 
"postphlebitic syndrome" are commonly used as 
definitive diagnoses without delineation of the physi- 
ologic or anatomic problem. Many, if not most, of the 
reports in the literature that deal with venous ulcer fail 
to define the clinical state in reproducible terms, so 
the reader is not informed whether the ulcer is due to 
disease in the superficial, deep, or perforator veins, 
whether the venous problem is one of reflux or of 
obstruction, or whether the cause of the problem is 
postthrombotic orprimary venous disease. With this 
amount of imprecision, it should come as no surprise 
that confusion over results of treatment and of diag- 
nosis is rampant in CVD. 
The challenge now is to convert he present state 
in which a few "facts" are mixed with a lot of 
supposition into a new state in which basic facts are 
established by scientific study that can be reliably 
reproduced and formulated into a set of guiding 
principles for CVD. To do this we will need prospec- 
tive studies of carefully defined clinical problems 
managed by alternative treatment techniques. These 
treatments need to be monitored by objective testing 
for a long enough period to establish their validity. 
This process has begun and will occur slowly and 
incompletely over time, but it can be facilitated by 
consciously defining our goals. 
In my estimation there are several steps that must 
be in place for good clinical research to occur: 
1. Define which patients are being treated. The 
process begins with precise diagnosis. The venous 
system is complex in its normal anatomy and physi- 
ology, and becomes far more complex in disease 
states. These complexities need to be identified by 
thorough pretreatment diagnosis achieved by objec- 
tive, reproducible t sting procedures. The new CEAP 
(clinical, etiologic, anatomic, pathophysiologic) clas- 
sification of the AVF provides astart in this direction.5 
2. Define which tests to use when. There need 
to be recommendations of minimum testing to jus- 
tify a given diagnosis. The specificity and the accu- 
racy of various tests for specific pathologic problems 
remains to be defined. Because the variability of 
venous testing is immense from one institution to 
another, quality control standards are necessary for 
vascular laboratories. 
3. Prospective studies. Armed with thorough 
diagnoses that are reproducible from institution to 
institution, and using testing methods of comparable 
reliability from institution to institution, prospective 
interinstitutional case series can be designed with 
adequate numbers of cases to produce conclusive 
results in a reasonable period of time. These series can 
compare surgical and medical variations in the man- 
agement of comparable problems (apples to apples). 
In this way, definitive diagnoses can be used to study 
variations in definitive treatment alternatives. 
4. Adequate follow-up. CVD, like a glacier, 
moves slowly but forcefully over time. There are 
dynamic hanges that demand long-term follow-up if 
correct conclusions are to be reached. Two-year 
results are likely to be misleading. Five-year esults 
may be a minimum time. Eight- to 10-year results are 
about as long as follow-up can be practical because 
patients move away, change lifestyles, develop new 
illnesses, die, or become too disinterested. In addition 
to simple follow-up in CVD, there needs to be a 
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comparison of the preoperative and postoperative 
activity level of the patient before it can be concluded 
that a treatment has been successful. 
A NEW BEGINNING 
The CEAP classification. With the critical prob- 
lem of confused communication with regard to CVD 
in mind, an international panel of experts gathered in 
1994 under the auspices of the AVF to develop a 
consensus statement about he diagnosis and classifi- 
cation of CVD. 6 The result was the new CEAP 
method of classification, in which the elements of a 
correct diagnosis in CVD were determined to be the 
clinical condition, the etiologic mechanism of the 
condition, the anatomic distribution of the problem, 
and the pathophysiologic mechanism of the develop- 
ment of the problem. 
These categories were developed into an acronym 
much as we use to describe malignant umors, ~in 
which each main category has subcategories and a 
shorthand method is used to express the condition. In 
the CEAP classification there are six subheadings 
under Clinical condition, three under Etiologic 
mechanism, three main headings under Anatomy that 
are subdividable into eighteen segments, and three 
headings under Pathophysiology. A cryptic method of 
expressing a thorough diagnosis emerges. For ex- 
ample, "C2,3-a-Ep-As-Pr2,3" describes a case of 
varicose veins with swelling, free of pain; caused by 
primary venous disease; limited to the superficial 
veins; having reflux in the greater saphenous vein of 
the thigh and calf as the mechanism of develop- 
ment."C2,4,6-s-Es-As,d,p-Pr2,3,14,15,18-o13"de- 
scribes acase of varicose veins with stasis kin changes 
and ulceration, accompanied by pain; caused by 
postthrombotic disease; affecting the saphenous, 
deep, and perforator veins; causing reflux in the entire 
greater saphenous vein and in the popliteal and crural 
veins and in the calf perforator veins, and obstruction 
in the superficial femoral vein. 
This clearly is a new standard of diagnosis in CVD 
that will require a learning curve for all of us to master. 
The consensus committee wrestled with the dilemma 
of a complicated but thorough definitive diagnosis 
versus the need to keep it short and simple enough to 
be practical. It concluded that anything less than its 
present form would be incomplete and would negate 
the effort to achieve reproducible diagnoses in CVD. 
In adopting this format, the committee recognized 
that CVD is complex and cannot be oversimplified if 
it is to be understood. For too long we have under- 
estimated and underdiagnosed chronic venous prob- 
lems, with the result hat our understanding ofthem 
Table I. Elements of vascular 
diagnoses--classification 
Arterial Venous 
foot ulcer leg ulcer C 
atherosclerosis vs embolic primary vs postthrombotic E 
femoral-popliteal deep (fem-pop-tib) A 
stenosis/occlusion reflux/obstruction P 
remains incomplete up to the present time. The 
elements of the CEAP classification are analogous to 
the elements customarily included in the diagnosis of 
arterial problems in which we determine the cause, 
the anatomic distribution, and the pathophysiologic 
mechanism in each clinical condition (Table I). 
The ad hoc committee went further and, in an 
addendum to the actual classification, provided sug- 
gestions for judging the severity of the venous insuf- 
ficiency by grading the signs and symptoms of the 
disease process. It also described the specific applica- 
tions of the various tests used in CVD. 5 
Publication of the document has been carried out 
around the world during the past 18 months. It has 
been officially adopted in the United States by The 
American Venous Forum and the North American 
Society of Phlebology, approved by the joint council 
of the Society for Vascular Surgery/International 
Society for Cardiovascular Surgery, North American 
Chapter, and published in the Update of the Report- 
ing Standards in Venous Disease as the new standard 
for reporting in CVD, 7 and has been published in the 
dermatologic literature, s It has or soon will appear in 
vascular and phlebologic journals in the United States 
and around the world, including Japan, Australia, 
South America, and multiple journals throughout 
Europe including England, France, Germany, Aus- 
tria, and Italy. It has been translated into French, 
German, Italian, Japanese, and Spanish. Worldwide 
acceptance of this single classification is necessary to 
ensure proper communication i ternationally. 
Many problems will surface with implementation 
of the CEAP method, and these problems will need to 
be processed over time. But it is a beginning. The 
experience of having an international group reach 
consensus speaks to the marvelous ability of Dr. An- 
drew Nicolaides to conduct a consensus conference 
and represents a pinnacle of cooperation among clini- 
cians and scientists around the world to come to- 
gether and embrace a solution to a common problem. 
Personal experience with CEAP. To evaluate the 
CEAP classification and test the value of highly 
specific diagnoses, we have examined two series of 
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Fig. 1. Series I. CEAP classification f 102 consecutive cases of CVD. (Reprinted from Kistner 
RL, Ekl0fB , Masuda EM. Mayo Clin Proc 1996;71:338-45.) 
patients. Series I was a consecutive series of 102 
patients who had any complaint of chronic venous 
insufficiency. Series II was a consecutive series of 56 
venous ulcers. 
Each patient was evaluated with a history, a 
physical examination, and a color-flow Doppler scan 
performed by an experienced vascular surgeon. Ad- 
ditional tests began with duplex scanning for all 
patients who had clinical findings beyond the level of 
telangiectasia and branch varicose veins. Plethysmog- 
raphy (using air plethysmography in most cases), 
venous pressure, and ascending and descending phle- 
bography were applied selectively to define aspects of 
the diagnosis in more complicated problems. 
The results of these two series are presented in 
Figs. 1 and 2.9 Points of particular interest included a
great predominance ofprimary disease in both series 
I (86%) of consecutive CVD cases and in series II 
(71%) limited to the ulcer population. There was also 
an 8-to-9:1 predominance of reflux disease over 
obstructive disease in both groups; this finding is 
consistent with the literature and is demonstrative of 
the dominating clinical importance of axial reflux in 
CVD. 
In series I (consecutive chronic venous cases) 
there was a high proportion of minor problems 
presenting as telangiectases and minor varicose veins, 
some of which did not involve the saphenous vein 
itself. These problems are managed with a minimum 
of diagnosis and treated with sclerotherapy; they 
demonstrate he huge numbers of these problems in 
the population. In spite of this, 23% of the series had 
skin changes and 14% had ulcer problems. These 
percentages would vary widely from series to series, 
but the knowledge of their distribution isof value for 
any practice in its own self-analysis. 
In the breakdown analysis of anatomic involve- 
ment in the ulcer series, reflux was limited to the 
saphenous veins in 29% of cases that were caused by 
primary disease and in none of the cases that were 
caused by postthrombotic disease; this finding iden- 
tifies a marked difference between the two causes. 
These superficial primary cases are a specific group of 
patients whose ulcers are amenable to cure by simple 
saphenous vein surgery. Those ulcers in the primary 
cases with saphenous plus perforator incompetence 
and a competent deep system by duplex study (32%) 
are also amenable to excellent results by relatively 
simple outpatient surgery) ° 
The finding that primary disease was the cause in 
70% of ulcer cases in series II supports the need for 
definitive diagnoses to include the cause of the con- 
dition before comparing results between series. If the 
series had 70% of ulcers caused by postthrombotic 
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Fig. 2. Series II. CEAP classification in 56 cases of venous ulceration. 
disease, any treatment method might have quite 
different results over the long term. 
The ulcer cases with secondary (postthrombotic) 
cause were different from the primary cases in that 
every secondary case showed deep vein disease, as 
opposed to 50% with deep vein disease in the primary 
cases. In addition, the saphenous vein (75%) and the 
perforators (81%) were usually involved. This finding 
speaks to the presence of widespread venous derange- 
ment in those postthrombotic cases that develop 
ulceration. In our experience, postthrombotic cases 
develop higher ecurrence rates after deep vein recon- 
struction than do primary cases if observed long 
enough (at least 4 to 6 years) n (Fig. 3), and we 
attribute this to the supposition that the venous 
derangement is greater in these xtensive postthrom- 
boric patients than it is in most of the primary cases. 
There are important differences between primary 
and secondary venous disease. The morphologic 
difference between the extensive intraluminal venous 
destruction found in the postthrombotic vein and the 
normal-appearingintima of the primary refluxing vein 
is dramatic. Because the clinical symptoms may be 
identical while the pathologic changes are vastly 
different, he clinical diagnosis i not a good predictor 
of the extent of venous damage. Physiologically, 
primary disease produces pure reflux, whereas post- 
thrombotic disease may cause pure reflux, nearly pure 
obstruction, or mixed reflux and obstructive changes. 
The difference between primary and secondary also 
extends to treatment where the long-term results of 
reconstruction for primary reflux are better than those 
of postthrombotic reflux (Fig. 3) in most of the 
published series, lz-15 
A striking finding that emerged from analysis of 
the anatomic distribution in the ulcer series was that 
axial reflux in both thigh and calf was present in 51 of 
53 cases (96%). Of the two exceptions, there was 
isolated perforator disease in one case, and in the 
other case the reflux was isolated to the popliteal-tibial 
plus the perforator veins. Both of these cases were of 
primary cause. 
The conclusion from these observations is that the 
CEAP classification, using objective testing appropri- 
ate to the severity of the clinical problem, has practical 
results in sorting out patients for surgery and other 
treatment. At the same time, it affords the opportu- 
nity to interrelate the clinical, anatomic, etiologic, and 
pathophysiologic phenomena of CVD to each other. 
INFLUENCE OF SPECIFIC DIAGNOSIS 
ON TREATMENT 
If the concept of a thorough diagnosis that re- 
quires specific testing is to be accepted by the public, 
it will be important to demonstrate hat the additional 
testing pays off by effecting an improvement in the 
management of the patient. At present, physicians are 
in a quandary about how to treat patients who have 
serious chronic venous tates, such as advanced skin 
changes and ulceration. An example isthe comparison 
of the management of venous ulcer patients by 
medical and by surgical methods according to today's 
literature. To date, it is inappropriate ocompare the 
results of published series that were treated medically 
with those treated surgically because the medical cases 
are not thoroughly diagnosed and do not represent a 
uniform population, whereas the patients in the 
reconstructive surgical group have all undergone 
thorough workups to plan surgery, and they do 
represent a relatively tmiform population. The medi- 
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mixed causes. (Reprinted from Masuda EM, Kistner RL. J Vase Surg 1994;19:391-403.) 
cal series may consist of mixtures of primary and 
secondary reflux; mixtures of reflux and obstruction; 
some with proximal disease, others with distal disease, 
and some with both. Even the clinical status may be 
quite different because the reconstructive surgical 
cases by and large represent patients who have recur- 
rent difficult problems that failed to respond to 
simpler treatment methods, whereas the medical cases 
vary from first-time clinical cases to end-stage 
non-surgically repairable venous insufficiency. 
I have a favorite slide that is appropriate to this 
point. It shows six extremities in different patients in 
all of whom the findings would prompt the term 
"postphlebitic leg," but in whom definitive testing 
revealed six different diagnoses, and only one is a 
postthrombotic case. The others were one case each 
of ulceration caused by simple saphenous vein reflux, 
ulceration caused by isolated perforator reflux, ulcer- 
ation as a result of combined saphenous and perfora- 
tor incompetence, and advanced skin changes and a 
healed ulcer as a result of extensive primary reflux 
disease affecting saphenous, perforator, and deep 
veins. There was one case of 4+ skin changes and deep 
discoloration caused by repeated trauma in a diabetic 
patient whose veins were normal. Of these extremi- 
ties, four were a result of strictly primary venous reflux 
disease, one had no venous disease, and only one had 
postthrombotic disease. The external appearance of 
"postphlebitic syndrome" would have been in error 
in five of the six cases. 
The most important aspect of these six extremities 
are the implications for treatment: he one with no 
venous disease needs no treatment; he three with 
superficial and perforator primary reflux disease can 
be treated with outpatient surgery and can expect o 
be cured because the deep systems are normal; the one 
with extensive primary disease in saphenous, perfora- 
tor, and deep veins requires aphenous and perforator 
surgery and may require deep vein valvuloplasty 
depending on the response; and the one with exten- 
sive postthrombotic changes would also be surgically 
managed by obliteration of the saphenous and perfo- 
rator veins, but the deep reconstruction, if needed, 
would be achieved by a valve substitution rather than 
a valve repair method. 
In analysis of the CEAP experience from series I
and series II, at least four points stand out. 
First, in ulcer cases whose cause is primary disease, 
one fourth were caused by pure saphenous reflux and 
another one fourth were a result of combined saphe- 
nous and perforator reflux in the presence of a normal 
deep system. These patients are readily treatable by 
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performing outpatient surgery on the saphenous and 
perforator veins and can be expected to have a very 
high rate of long-term cure. ~6 This experience is not 
unique, having been reported in other series, 17 but the 
important thing is that these patients represent a large 
group of ulcer cases that are amenable to relatively 
simple surgery, and many of these patients can expec t 
to be free of the need to wear support stockings 
indefinitely. 
There is a common belief that all patients who 
have a venous ulcer will need to wear elastic stockings 
for the rest of their lives, regardless of the treatment 
method used. This is just not true. Vein stripping for 
patients who have reflux limited to the saphenous, and 
vein stripping plus perforator interruption for those 
who have combined primary reflux limited to saphe- 
nous and perforator veins, will be permanently cura- 
tive with relief of need for elastic support in >80% or 
more of cases/° This alone constitutes adequate 
reason for an accurate workup. Add to these our 
long-term follow-up of patients who have advanced 
primary deep vein disease treated surgically by valvu- 
loplasty, in whom 73% were free of recurrent ulcer- 
ation after 10 years, and in whom 30% stopped 
wearing elastic support n and were free of recurrence. 
When all of these cases are accounted, up to half of all 
patients who have an ulcer can be relieved of elastic 
support after selective surgery. 
Second, all of the patients who had ulcers as a 
result of postthrombotic disease had involvement of 
the deep veins. The pathophysiologic mechanism of 
this deep vein involvement usually consists of a 
combination of reflux and obstruction, with one or 
the other being physiologically dominant. In contrast, 
only half of the ulcer cases caused by primary disease 
had deep vein involvement, and this was invariably 
pure reflux. This difference accounts for a much better 
prognosis for surgical therapy in primary disease than 
in secondary disease. 
Third, of the cases that had venous ulceration, 96% 
were found to have reflux or obstruction i  both the 
thigh and the calf. Although this finding is consistent 
with the importance of the popliteal valve as the 
gatekeeper of the deep veins of the lower leg, ~8 it 
emphasizes the importance of proximal reflux in cases 
with advanced signs of venous insufficiency/9 The 
reflux that causes ulceration can be localized to just 
the superficial veins or can involve superficial nd deep 
veins; cases with only deep vein reflux appear to have 
pain but are not likely to develop ulcers or skin 
changes. 
Fourth, reflux dominates over obstruction as a 
cause of ulceration and of advanced skin changes. It is 
the sole pathophysiologic finding in the primary cases, 
and it occurs together with obstruction in the post- 
thrombotic ases. In the latter case, either reflux or 
obstruction may dominate physiologically. 
The importance of specific and complete diag- 
noses extends to the medically treated as well as the 
surgically treated CVD cases. In the medical cases, 
there are choices of therapy and questions of medica- 
tions and dressings that require investigation. At this 
point, we do not know if the site of the disease or the 
response of an obstructed versus a refluxing venous 
system makes a difference in nonsurgical treatment 
results. It is likely, but not proven, that the long-term 
clinical behavior of an extremity that is symptomatic 
on the basis of primary reflux in the saphenous vein 
will behave better than a similar degree ofpostthrom- 
boric reflux mixed with obstruction that affects the 
deep and the saphenous veins. 
PERSPECTIVE 
The CEAP classification, asimportant as it is, only 
represents a beginning. It remains to define the 
testing process more precisely. The limits of reliability 
of a given test in a given pathologic state need to be 
agreed on and published, and the reliability of these 
tests needs to be standardized in each laboratory to 
provide interinstitutional p rity and lead to reproduc- 
ible results in clinical practice. A consensus conference 
on this subject is to be held later this year in Europe 
under the leadership of Dr. Nicolaides and the Inter- 
national Union of Angiology and will include the 
participation ofAVF members. This is a necessary step 
in building toward interinstitutional studies and re- 
producible results. "~ 
Until the use of the CEAP classification for 
completeness of diagnosis and the employment of 
reliable tests to accurately identify pathologic prob- 
lems are in place, we will not be able to conduct he 
large-scale clinical studies with the statistical power 
afforded by larger numbers that will lead to sustain- 
able conclusions about the relative value of various 
treatment methods in clinical practice. 
CONCLUSION 
The field of CVD has been awaiting the advent of 
definitive, economical, and noninvasive safe testing 
methods. Now that we have these methods, we appear 
to be on the cusp of an explosion of scientific 
development in CVD. I believe a whole new attitude 
about venous disease will be required to progress from 
our present state where science is mingled with fiction 
to a new state of well-grounded, objectively tested 
facts in CVD that will stand the test of time. This 
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attitude will accept hat CVD is complex and impor- 
tant, and as such it requires definitive diagnoses based 
on objective criteria. In  current lingo, this represents 
a paradigm shift. 
It  is true that we only treat what we suspect to be 
present through the diagnostic evaluation of any 
patient. The importance of a complete diagnosis that 
meets the CEAP criteria lies in the information it 
affords for understanding of the disease process and 
selection of specific treatment for individual prob- 
lems. This facilitates choosing medical and surgical 
approaches and allows selection of surgical candidates 
for specific surgical procedures. It provides the basis 
for longitudinal nd interinstitutional studies of alter- 
native treatment techniques. This discipline over time 
will lead to new imaginative approaches to correct 
abnormalities of obstruction and incompetence. It is 
for these reasons that I believe specific diagnosis and 
specific treatment in CVD is a concept whose time has 
now come and that this will lead to the dawning of a 
new level of  scientific pursuit in CVD. 
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